Supernus Pharmaceuticals, Inc. (FRA:S49)
Germany · Delayed Price · Currency is EUR 41.20
+0.60 (1.48%)
At close: Jan 27, 2026
Supernus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -19.12 | 73.87 | 1.32 | 60.71 | 53.42 | 126.95 |
Depreciation & Amortization | 85.39 | 80.41 | 84.86 | 85.54 | 32.6 | 18.14 |
Other Amortization | - | - | 0.53 | 2.11 | 17.5 | 16.58 |
Asset Writedown & Restructuring Costs | - | - | 20.19 | - | 15 | - |
Loss (Gain) From Sale of Investments | -2.7 | 1.81 | -0.12 | 3.22 | 0.07 | -7.24 |
Loss (Gain) on Equity Investments | - | - | - | -12.89 | - | - |
Stock-Based Compensation | 31.03 | 27.76 | 26.76 | 17.57 | 17.91 | 16.56 |
Other Operating Activities | 6.2 | -9.85 | -13.31 | -15.2 | -12.94 | 3.92 |
Change in Accounts Receivable | -2.55 | 2.08 | 18.77 | -16.37 | 3.87 | -34.61 |
Change in Inventory | -0.14 | 15.81 | 6.11 | -17.86 | -14.58 | -10.12 |
Change in Accounts Payable | -24.49 | -15.02 | -36.29 | -19.16 | 18.18 | 8.27 |
Change in Other Net Operating Assets | -1.75 | -4.92 | 2.28 | 29.14 | -3.9 | -0.06 |
Operating Cash Flow | 71.88 | 171.95 | 111.09 | 116.83 | 127.13 | 138.4 |
Operating Cash Flow Growth | -58.33% | 54.79% | -4.91% | -8.10% | -8.14% | -3.31% |
Capital Expenditures | -1.12 | -0.73 | -0.55 | -0.41 | -2.05 | -3.69 |
Cash Acquisitions | -293.09 | - | - | - | -311.69 | -298.54 |
Investment in Securities | 337 | -189.14 | 269.28 | -216.25 | 231.82 | 267.53 |
Investing Cash Flow | 42.78 | -189.87 | 268.73 | -216.66 | -81.91 | -34.7 |
Short-Term Debt Issued | - | - | 93 | - | - | - |
Long-Term Debt Issued | - | - | - | - | 0.8 | - |
Total Debt Issued | - | - | 93 | - | 0.8 | - |
Short-Term Debt Repaid | - | - | -93 | - | - | - |
Long-Term Debt Repaid | - | - | -402.5 | - | -138.32 | -0.8 |
Total Debt Repaid | - | - | -495.5 | - | -138.32 | -0.8 |
Net Debt Issued (Repaid) | - | - | -402.5 | - | -137.52 | -0.8 |
Issuance of Common Stock | 35.94 | 14.91 | 6.61 | 12.42 | 7.1 | 4.36 |
Repurchase of Common Stock | -5.19 | -2.72 | -1.99 | - | - | - |
Other Financing Activities | -24.26 | - | - | -22.9 | - | - |
Financing Cash Flow | 6.49 | 12.19 | -397.88 | -10.48 | -130.42 | 3.56 |
Net Cash Flow | 121.15 | -5.72 | -18.07 | -110.31 | -85.21 | 107.26 |
Free Cash Flow | 70.75 | 171.23 | 110.53 | 116.41 | 125.08 | 134.71 |
Free Cash Flow Growth | -58.87% | 54.91% | -5.05% | -6.93% | -7.15% | -4.96% |
Free Cash Flow Margin | 10.38% | 25.87% | 18.19% | 17.45% | 21.57% | 25.89% |
Free Cash Flow Per Share | 1.26 | 3.06 | 1.99 | 1.89 | 2.30 | 2.51 |
Cash Interest Paid | - | - | 1.95 | 2.52 | 2.52 | 2.52 |
Cash Income Tax Paid | 28.69 | 53.25 | 36.6 | 16.2 | 25.19 | 45.43 |
Levered Free Cash Flow | 120.81 | 155.22 | 161.71 | 89.54 | 116.37 | 137.93 |
Unlevered Free Cash Flow | 120.81 | 155.22 | 162.69 | 91.84 | 113.51 | 136.2 |
Change in Working Capital | -28.93 | -2.05 | -9.14 | -24.24 | 3.57 | -36.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.